AbBC is a next generation ADC company that utilizes a biological conjugation process to target and deliver Granzyme B to cells for internalization and irreversible toxicity without the requirement of cleavage. Our pipeline of 7 fully human fusion proteins in ongoing preclinical development demonstrate inhibition and regression of tumor growth without toxicity. The platform enables the opportunity to methodically select ADC targets for development of new Granzyme B fusion proteins with major focus in oncology.
Company Details
- Employees
- 4
- Address
- Bolton, Massachusetts 01740, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://abbctherapies.com/
- HQ
- Bolton, Massachusetts
Abbc Therapies Questions
Abbc Therapies's website is https://abbctherapies.com/
Abbc Therapies's LinkedIn profile is https://www.linkedin.com/company/abbctherapies
Abbc Therapies has
4 employees.
View email and phone details for 4
employees at Abbc Therapies.
Abbc Therapies's industry is
Biotechnology Research
Abbc Therapies's top competitors are
Caris Life Sciences,
7 Hills Pharma,
Sarepta Therapeutics,
Boston Scientific,
Kimberly-Clark,
Accel Diagnostics, Llc.
Abbc Therapies's categories are Biotechnology Research
